The rapid rise of new weight-loss drugs is worrying investors in food companies. Food executives say they can handle what comes. “I still have a fully stocked kitchen, there’s chips and pretzels in there,” said one person taking the drugs. “I don’t find it tempting.” https://lnkd.in/gecbwbYG
Absolutely, it's crucial to consider the long-term impact of health choices. As someone who's experienced the journey from pre-diabetic and obese to a healthier lifestyle, I believe in the power of conscious food decisions. The news about Ozempic and the rise in appetite suppressant use by 2024 is noteworthy, but it's essential to remember that quick fixes aren't sustainable. Our grocery stores are filled with ultra-processed, nutrient-lacking options that provide temporary fullness but not lasting health. Let's take this opportunity to understand how food truly affects our bodies. Most illnesses today are preventable, and by making mindful choices, we can lead healthier lives.
Investors care more about their pocketbooks than people's health? SHOCKING.
Nothing says late-stage capitalism like Americans getting healthier presented as bad news because junk food sales are going down.
It will be interesting to see which food manufacturers work to produce healthier food options and not just change their packaging to satisfy trends... I also can't wait to see what FDA & FTC monitoring of these emerging practices will look like.
Interesting so after years of making food more addicting and unheathy, pharma comes with the "cure" and now food inc is considering its next move. Scary.
Forever in search of A Panacea...Just Do The Work! Walk more! Clean your home! It's a great workout. Cook your food. Blast some tunes while doing it. Whistle while ya work. Heart Healthy. :)
Very useful
Ozempic isn't a weight loss drug and its unfortunate its being portrayed that way. Its a great drug that helps with Type-2 diabetes by controlling blood sugar. The popularization of it for weight loss has distracted from its true purpose, and caused insurance companies to deny it for some people that could use it on early-stage diabetes prevention.